Currax Pharmaceuticals LLC

About

Currax Pharmaceuticals LLC is a Nashville-area pharmaceutical company headquartered in Brentwood, Tennessee, specializing in innovative medicines for patients with chronic and progressive diseases. The company operates as both a developer and distributor of branded and generic pharmaceutical products, maintaining a comprehensive portfolio that includes CONTRAVE, ONZETRA Xsail, SILENOR, and TREXIMET medications. As a vertically integrated pharmaceutical manufacturer, Currax Pharmaceuticals combines drug development capabilities with commercial distribution expertise to deliver life-changing treatments to patients worldwide. The company conducts clinical trials and provides independent research through educational grants, demonstrating commitment to advancing pharmaceutical science and patient care standards. Currax Pharmaceuticals has earned recognition as one of Nashville Business Journal Best Places to Work for three consecutive years, reflecting the company culture of challenging conventional pharmaceutical industry approaches while inspiring continuous innovation. Their manufacturing and development processes focus on chronic disease therapeutics, particularly in areas where patients face limited treatment options. The company strategic approach emphasizes enhancing medication access and improving patient outcomes through specialized pharmaceutical manufacturing and targeted drug development programs. Located in Tennessee thriving pharmaceutical corridor, Currax Pharmaceuticals leverages regional manufacturing advantages while maintaining global distribution capabilities for their branded product lines and generic pharmaceutical offerings.